FocalTherics (FOCL) Diversifiers

Equity · Currency in USD · Last updated Jun 6, 2026

FocalTherics, legally EDAP TMS S.A., develops, manufactures, and markets robotic energy-based medical devices for minimally invasive focal therapy. Its flagship Focal One robotic HIFU platform combines imaging, treatment planning, robotic precision, and high-intensity focused ultrasound technology for personalized prostate cancer therapy. The company began trading under ticker FOCL on Nasdaq on June 1, 2026 after changing its corporate identity from EDAP TMS.

Looking to balance out your exposure to FOCL? The ETFs below have the lowest correlation with FOCL — they tend to move on their own, which can help reduce risk when FOCL drops. The stock ideas table highlights individual companies that behave independently from FOCL.

No Diversifiers Found for FOCL

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements FOCL

Add FOCL to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with FOCL